HomeResource LibraryCompanies AssessedDechra PharmaceuticalsPrint

Dechra Pharmaceuticals

LSE:DPH GB0009633180
Follow
Key Information
HQ:
United Kingdom
Market Cap:
$4.79bn
Primary Markets:
Europe & Russia, North America

Company Information

Dechra